Article
p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis
18 Feb 2013
Abstract excerpt
The role of apoptosis in melanoma pathogenesis and chemoresistance is poorly characterized. Mutations in TP53 occur infrequently, yet the TP53 apoptotic pathway is often abrogated. This may result from alterations in TP53 family members, including the TP53 homologue TP63. Here we demonstrate that TP63 has an antiapoptotic role in melanoma and is responsible for mediating chemoresistance. Although p63 was not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
